Search by Drug Name or NDC
NDC 51407-0333-20 Cefuroxime axetil 250 mg/1 Details
Cefuroxime axetil 250 mg/1
Cefuroxime axetil is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Golden State Medical Supply, Inc.. The primary component is CEFUROXIME AXETIL.
MedlinePlus Drug Summary
Cefuroxime is used to treat certain infections caused by bacteria, such as bronchitis(infection of the airway tubes leading to the lungs); gonorrhea (a sexually transmitted disease); Lyme disease (an infection that may develop after a person is bitten by a tick); and infections of the skin, ears, sinuses, throat, tonsils,, and urinary tract. Cefuroxime is in a class of medications called cephalosporin antibiotics. It works by stopping the growth of bacteria. Antibiotics such as cefuroxime will not work for colds, flu, or other viral infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 51407-0333-20Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Cefuroxime
Product Information
| NDC | 51407-0333 |
|---|---|
| Product ID | 51407-333_f6cc658e-da1d-5b4c-e053-6294a90a8532 |
| Associated GPIs | 02200065050310 |
| GCN Sequence Number | 009136 |
| GCN Sequence Number Description | cefuroxime axetil TABLET 250 MG ORAL |
| HIC3 | W1X |
| HIC3 Description | CEPHALOSPORIN ANTIBIOTICS - 2ND GENERATION |
| GCN | 47281 |
| HICL Sequence Number | 003991 |
| HICL Sequence Number Description | CEFUROXIME AXETIL |
| Brand/Generic | Generic |
| Proprietary Name | Cefuroxime axetil |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Cefuroxime axetil |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 250 |
| Active Ingredient Units | mg/1 |
| Substance Name | CEFUROXIME AXETIL |
| Labeler Name | Golden State Medical Supply, Inc. |
| Pharmaceutical Class | Cephalosporin Antibacterial [EPC], Cephalosporins [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA065496 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 51407-0333-20 (51407033320)
| NDC Package Code | 51407-333-20 |
|---|---|
| Billing NDC | 51407033320 |
| Package | 20 TABLET, FILM COATED in 1 BOTTLE (51407-333-20) |
| Marketing Start Date | 2021-01-29 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |